Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Soleno Therapeutics (SLNO) Change in Cash (2016 - 2019)

Historic Change in Cash for Soleno Therapeutics (SLNO) over the last 7 years, with Q4 2019 value amounting to $9.5 million.

  • Soleno Therapeutics' Change in Cash fell 2327.31% to $9.5 million in Q4 2019 from the same period last year, while for Dec 2019 it was -$2.4 million, marking a year-over-year decrease of 13967.14%. This contributed to the annual value of -$81.8 million for FY2024, which is 15271.7% down from last year.
  • Latest data reveals that Soleno Therapeutics reported Change in Cash of $9.5 million as of Q4 2019, which was down 2327.31% from -$4.3 million recorded in Q3 2019.
  • Soleno Therapeutics' Change in Cash's 5-year high stood at $12.4 million during Q4 2018, with a 5-year trough of -$4.3 million in Q3 2019.
  • For the 5-year period, Soleno Therapeutics' Change in Cash averaged around $637064.3, with its median value being -$2.0 million (2015).
  • In the last 5 years, Soleno Therapeutics' Change in Cash tumbled by 55022.52% in 2015 and then soared by 68365.1% in 2017.
  • Over the past 5 years, Soleno Therapeutics' Change in Cash (Quarter) stood at $774813.0 in 2015, then tumbled by 446.99% to -$2.7 million in 2016, then surged by 526.0% to $11.5 million in 2017, then increased by 8.2% to $12.4 million in 2018, then fell by 23.27% to $9.5 million in 2019.
  • Its Change in Cash stands at $9.5 million for Q4 2019, versus -$4.3 million for Q3 2019 and -$3.9 million for Q2 2019.